Email: yaugusti@sgul.ac.uk
Tel: 0208 725 5722
Twitter: @DrYolandaAugus1
Biography
Dr Yolanda Augustin is a Malaysian oncologist with a special interest in sarcoma and global oncology. She did her undergraduate, medical and palliative care training at Guy's, King's and St Thomas School of Medicine before undertaking clinical oncology training at the Royal Marsden, London. Upon completion of her oncology training, she undertook a research fellowship with the Royal Marsden Sarcoma Unit and obtained higher training in clinical trial design and delivery for novel systemic anticancer therapies including immunotherapy and radiotherapy as part of an extensive clinical trial portfolio. She currently collaborates with oncology colleagues in Malaysia on sarcoma service development, research and training.
She co-leads a global oncology programme at St George's, University of London focused on developing affordable therapeutics and diagnostics for cancer and infectious disease in Low and Middle-Class Income Countries (LMICs). The programme brings together interdisciplinary experts from academia, global health and industry, with research collaborations in Malaysia, Vietnam, India and Senegal. Their current projects are focused on artesunate drug repurposing for cancer, affordable point-of-care diagnostics for HPV DNA screening for cervical cancer and advocacy work with community health care champions and local stakeholders in rural communities on removing barriers to equitable healthcare access and cancer service delivery.
Krishna S, Augustin Y. The UK Government’s Pandemic Shame. Project Syndicate, March 2021. https://www.project-syndicate.org/commentary/uk-government-covid19-personal-protective-equipment-shortages-by-sanjeev-krishna-and-yolanda-augustin-1-2021-03
Krishna S, Augustin Y. Britain’s Vaccine Gamble. Project Syndicate, Jan 2021.
https://www.project-syndicate.org/commentary/uk-delay-second-dose-covid19-vaccine-by-sanjeev-krishna-and-yolanda-augustin-1-2021-01?barrier=accesspaylog
Krishna S, Augustin Y, Wang J, Xu C, Staines HM, Platteeuw H, Kamarulzaman A, Sall A, Kremsner P. Repurposing Antimalarials to Tackle the COVID-19 Pandemic. Trends Parasitol. 2021 Jan;37(1):8-11. doi: 10.1016/j.pt.2020.10.003. Epub 2020 Oct 19. PMID: 33153922; PMCID: PMC7572038.
Augustin Y, Staines HM, Krishna S. Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing. Pharmacol Ther. 2020 Dec;216:107706. doi: 10.1016/j.pharmthera.2020.107706. Epub 2020 Oct 16. PMID: 33075360; PMCID: PMC7564301.
Younger E, Smrke A, Lidington E, Farag S, Ingley K, Chopra N, Maleddu A, Augustin Y, Merry E, Wilson R, Benson C, Miah A, Zaidi S, McTiernan A, Strauss SJ, Dileo P, Gennatas S, Husson O, Jones RL. Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 Pandemic. Cancers (Basel). 2020 Aug 14;12(8):2288. doi: 10.3390/cancers12082288. PMID: 32823999; PMCID: PMC7547383.
Staines HM, Kirwan DE, Clark DJ, Adams ER, Augustin Y, Byrne RL, Cocozza M, Cubas-Atienzar AI, Cuevas LE, Cusinato M, Davies BMO, Davis M, Davis P, Duvoix A, Eckersley NM, Forton D, Fraser AJ, Garrod G, Hadcocks L, Hu Q, Johnson M, Kay GA, Klekotko K, Lewis Z, Macallan DC, Mensah-Kane J, Menzies S, Monahan I, Moore CM, Nebe-von-Caron G, Owen SI, Sainter C, Sall AA, Schouten J, Williams CT, Wilkins J, Woolston K, Fitchett JRA, Krishna S, Planche T. IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Emerg Infect Dis. 2021 Jan;27(1):85–91. doi: 10.3201/eid2701.203074. Epub 2020 Nov 30. PMID: 33256890; PMCID: PMC7774532.
Lee JY, Cutts RJ, White I, Augustin Y, Garcia-Murillas I, Fenwick K, Matthews N, Turner NC, Harrington K, Gilbert DC, Bhide S. Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC). Front Oncol. 2020 Apr 17;10:505. doi: 10.3389/fonc.2020.00505. PMID: 32363162; PMCID: PMC7180612.
Augustin Y, Krishna S, Kumar D, Pantziarka P. The wisdom of crowds and the repurposing of artesunate as an anticancer drug. Ecancermedicalscience. 2015 Oct 13;9:ed50. doi: 10.3332/ecancer.2015.ed50. PMID: 26557887; PMCID: PMC4631583.
Augustin YS, Birch M, Bodini C, Boulton F, Robertson E, Spada VM, Weingarten M. Prevention of torture by doctors and organisations. Lancet. 2011 Dec 17;378(9809):e22-3. doi: 10.1016/S0140-6736(11)61300-7. Epub 2011 Sep 7. PMID: 21906800.
Augustin YS, Anwar NI, McCoy D (2008) ’The Healthcare Sector :Prisoners’ In the Global Healthwatch Report 2: An Alternative World Health Report. London & New York :Zed Books
Augustin YS ‘Buying Cake IS our job’, BMJ. 2007 335(7616): 379 PMCID: PMC1952492
British Sarcoma Group Conference, United Kingdom, February 2021
Myxoid Liposarcoma: Evaluation of Response to Radiotherapy, Surgical and Clinical Outcomes at the Royal Marsden Sarcoma Unit between 1990-2018 (presentation)
Gastrointestinal Stromal Tumours: Radiotherapy Treatment and Clinical Outcomes at The Royal Marsden Sarcoma Unit 2010-2019 (poster)
Pleomorphic dermal sarcoma and atypical fibroxanthoma of the scalp: Review of Surgical, Radiotherapy Management and Clinical Outcomes at The Royal Marsden Sarcoma Unit 2010-2019 (poster)
UK SABR Consortium Conference, United Kingdom, November 2020
World Academy of Science (TWAS) Young Affiliate Network (TYAN) and Young Scientists Network–Academy of Sciences Malaysia (YSN-ASM), Malaysia Nov 2018
Phase II Randomised Double Blind Placebo Controlled Trial of Neoadjuvant Artesunate in Stage II/III Colorectal Cancer
American Society of Radiation Oncology (ASTRO), United States Sept 2017
Stereotactic body radiotherapy for pelvic re-irradiation: review of dose, toxicity and clinical outcomes.